Scientists have discovered a new weakness in lung cancer that could lead to better treatments and help prevent the disease ...

Treatment resistance and relapse in the most common type of lung cancer can be traced to a protein called agrin, according to ...

Mutations in the oncogene KRAS are widespread in several human cancers, including pancreatic ductal adenocarcinomas (92%), colorectal carcinomas (49%) and lung adenocarcinomas (35%). These mutations ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

Most of us would probably think of smoking or air pollution when it comes to lung cancer risk, but researchers have ...

Engineering Research Center of Molecular and Neuro Imaging, Ministry of Education School of Life Science and Technology, Xidian University, Xi’an, Shanxi 710071, P. R. China ...

NSCLC accounts for 85% of lung cancers and is further classified into three major histopathological subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma (1). Given the lung’s ...

New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...

We all know at this point that high-sugar diets are not good for us. They increase our risk of developing cardiovascular ...

Objective: This study aims to evaluate the prognostic significance of peripheral blood biomarkers in relation to outcomes and immune-related adverse events (irAEs) among patients with stage IV driver ...

Moreover, the location of the tumor—whether in the airways (as with bronchioloalveolar adenocarcinoma) or in lung tissues themselves—can also have an impact on survivability. While research on each ...

It has not become cancer yet and has not spread anywhere else. Doctors sometimes call this stage “carcinoma in situ” or Bowen disease. Stage 0 cancer may or may not be visible. If it is ...